DRUG · Mapped RxNorm record
Dolutegravir
Normalized identity: dolutegravir View linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Pharmacokinetics and Safety of DolutegravIr in Neonate
NCT05590325
Study summary
ClinicalTrials.govPharmacokinetics and Safety of DolutegravIr in Neonate
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE1, PHASE2
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Advertisement
Conditions
Hivunresolved
Interventions
DolutegravirDRUG · verified · RxNorm: dolutegravir
Sponsors & collaborators
Desmond Tutu TB Centrelead sponsor
Chiang Mai Universitycollaborator
UNITAIDcollaborator
University of Stellenboschcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05590325 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.